PERGOLIDE MESYLATE - NEW THERAPY FOR PARKINSON DISEASE

被引：4
|
作者：
TANNER, CM [1 ]
KLAWANS, HL [1 ]
机构：
[1] RUSH PRESBYTERIAN ST LUKES MED CTR, MED CTR, DEPT PHARMACOL, CHICAGO, IL 60612 USA
来源：
ANNALS OF INTERNAL MEDICINE | 1982年 / 96卷 / 04期
关键词：
D O I：
10.7326/0003-4819-96-4-522
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：522 / 523
页数：2
相关论文
共 50 条
  • [21] STEREOCHEMISTRY OF DOPAMINERGIC ERGOLINE DERIVATIVES - STRUCTURES OF PERGOLIDE AND PERGOLIDE MESYLATE
    MA, LYY
    CAMERMAN, N
    SWARTZENDRUBER, JK
    JONES, ND
    CAMERMAN, A
    CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1987, 65 (02): : 256 - 260
  • [22] Ropinirole versus pergolide as adjunctive therapy to levodopa (LD) in Parkinson's disease
    Unal, Z.
    Boylu, E.
    Orhan, S.
    Deniz, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 247 - 247
  • [23] Pergolide mesylate (Permax®) as adjuvant treatment of Parkinson's disease-prospective, open 6-month study
    Bares, M
    Rektor, I
    Kanovsky, P
    Hortová, H
    Streitová, H
    Kubová, D
    Rektorová, I
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2001, 64 (04) : 231 - 236
  • [24] Pergolide pharmacokinetics in patients with Parkinson's disease
    Thalamas, C
    Rascol, O
    Blin, O
    Kulisevsky, J
    Rajman, I
    Brefel-Courbon, C
    MOVEMENT DISORDERS, 2002, 17 : S47 - S47
  • [25] High dosage of pergolide in Parkinson's disease
    Kizilay, F
    Ozkaynak, S
    MOVEMENT DISORDERS, 2004, 19 : S274 - S274
  • [26] Pergolide monotherapy titration in Parkinson's disease
    Nausieda, P
    Stern, M
    Hubble, J
    Silver, D
    Wess, M
    Watts, R
    MOVEMENT DISORDERS, 2002, 17 : S87 - S87
  • [27] PERGOLIDE IN LATE-STAGE PARKINSON DISEASE
    LANG, AE
    QUINN, N
    BRINCAT, S
    MARSDEN, CD
    PARKES, JD
    ANNALS OF NEUROLOGY, 1982, 12 (03) : 243 - 247
  • [28] FURTHER-STUDIES WITH PERGOLIDE IN PARKINSON DISEASE
    LIEBERMAN, AN
    GOLDSTEIN, M
    GOPINATHAN, G
    LEIBOWITZ, M
    NEOPHYTIDES, A
    WALKER, R
    HIESIGER, E
    NELSON, J
    NEUROLOGY, 1982, 32 (10) : 1181 - 1184
  • [29] Efficacy of pergolide mesylate in refractory depression
    Fukunaga, T
    Kotorii, N
    Omori, M
    Sakamoto, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S29 - S29
  • [30] Sclerosing mesenteritis: An ergot-related complication of pergolide therapy in Parkinson's disease?
    Bharucha, Kersi J.
    Blevins, Steve M.
    MOVEMENT DISORDERS, 2008, 23 (06) : 922 - 923
12345